Evidence map›Paper›PMID 38628522›Full record

ArticleSurgical neurology international2024

Primary extranodal marginal zone mucosa-associated lymphoid tissue-type B-cell lymphoma involving the dura: A case report.

Ryo Hamamoto, Toshinari Kawasaki, Masashi Oda, Sosuke Sumiyoshi, Kosuke Hayashi, Tamaki Kobayashi, Yoshihiko Ioroi, Tatsuki Uchiyama, Motohiro Takayama, Masaaki Saiki

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. IntracranialBritish journal of biomedical science · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ryo HamamotoDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Toshinari KawasakiDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Masashi OdaDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Sosuke SumiyoshiDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Kosuke HayashiDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Tamaki KobayashiDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Yoshihiko IoroiDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Tatsuki UchiyamaDepartment of Hematology Japanese Red Cross Otsu Hospital, Otsu, Japan.
Motohiro TakayamaDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Masaaki SaikiDepartment of Neurosurgery Japanese Red Cross Otsu Hospital, Otsu, Japan.
Otsu Red Cross Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Primary extranodal marginal zone mucosa-associated lymphoid tissue-type B-cell lymphoma (EMZMBCL), which presents as a dural mass, is a rare intracranial tumor that mimics a subdural hematoma or meningioma. Case Description: A 49-year-old woman presented to our hospital with transient right upper limb paresis, dysarthria for 10 min, and ongoing right upper-limb numbness. Computed tomography (CT) of the head revealed extra-axial lesions in the left frontal and parietal lobes. Based on the initial CT findings in the emergency room, an acute subdural hematoma was suspected. However, meningiomas and other intracranial tumors were also listed as differential diagnoses because there was no history of head trauma or coagulation abnormalities on blood examination, and further imaging studies were performed. Imaging findings suggested a subdural neoplastic lesion. A partial resection was performed for the lesion. Based on histopathological and immunohistochemical examinations, the patient was diagnosed with EMZMBCL. Whole-brain and intensity-modulated radiation therapies were administered as adjuvant therapies. The patient was discharged without neurological deficits. Conclusion: EMZMBCL is a rare disease that should be considered in the differential diagnosis of subdural lesions, especially when there is no history of trauma or abnormalities in the coagulation system. The patient had a favorable outcome after selecting radiotherapy as the adjuvant therapy.

Indexed as

Intracranial tumorMeningiomaPrimary extranodal marginal zone mucosa-associated lymphoid tissue-type B-cell lymphomaRadiotherapySubdural hematoma

Identifiers

PMID38628522
PMCPMC11021089
OpenAlexW4393316856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.